March 8, 2025
admin
Paramesu Biotech IPO GMP, Details, Guidance, Subscription Status, allotment @ Chanakyanipothi.com
A legacy of 31 Years.
India`s Oldest Investment & IPO website.
Most Trusted by Investors across India.
Table of Contents
- GMP
- Reviews
- Subscription
- Allotment
What is the latest news relating to Paramesu Biotech IPO?
On 28th February 2025, the company has received green signal to its IPO.
What is the latest GMP of Paramesu Biotech IPO?
Click
Paramesu Biotech IPO Subscriptions
|
|||||
| QIB | B HNI X | S HNI X | NII X | RII X | Total X |
| Applications: / (?x) Amount wise Bids recd. Rs. ? Crore |
|||||
What are the promoters of Paramesu Biotech IPO?
THE PROMOTERS OF OUR COMPANY ARE: UNIMARK BUSINESS SOLUTIONS PRIVATE LIMITED, SPEEDFAST TRACOM LIMITED, ANANDA SWAROOP ADAVANI, MANI SWETHA TETALI AND HIMABINDU TETALI
What are the Objects of Paramesu Biotech IPO?
The Company intends to utilise the Net Proceeds from the Issue towards funding the following objects:
- Funding the capital expenditure requirement for setting up of new plant of 1200 TPD at the Proposed Facility in Mohasa – Babai, District Narmadapuram, Madhya Pradesh.
- 2. Repayment and/ or pre-payment, in part or full, of certain borrowings availed by the Company; and
- 3. General Corporate Purposes.
What is the business of Paramesu Biotech?
Paramesu Biotech is one of India’s largest manufacturers of maize-based specialty products, with an installed capacity of 800 TPD (tons per day) (Source: F&S Report). The company offers a diverse range of maize-based products, including native maize starch, modified maize starches, liquid glucose, maltodextrin powder, and co-products like germs, gluten, fiber, corn steep liquor, and enriched fiber.
With a capacity utilization rate of 93.09% in FY 2024, Paramesu Biotech stands out among its peers (Source: F&S Report). It is one of the few companies in India specializing in various types of modified starches, including dextrin, pre-gelatinized starch, thin boiled starch, cationic starch, oxidized starch, and spray starch (Source: F&S Report).
The company operates its production unit in Devarapalli, West Godavari District, Andhra Pradesh, and has established a strong presence both domestically and internationally. Paramesu Biotech’s products are sold across 14 states and 4 union territories in India, and the company exports to over 10 countries in South East Asia and the Middle East. It is also a recognized Two Star Export House by the Indian Ministry of Commerce.
The company’s Devarapalli facility, covering 2.63 million square feet (approximately 60.29 acres), is strategically located near major maize harvesting regions, export ports, and key transport routes, optimizing its business operations.
For more information, click www.paramesu.com
Paramesu Biotech IPO GMP, Particulars & Guidance
| IPO Details | |
| IPO opens on | Yet to announce |
| IPO closes on | Yet to announced |
| Issue Type | Book Built Issue IPO |
| Issue Size | ? Sh / Rs 600 Crore |
| * Fresh Issue | ? Sh / Rs 520 Crore |
| * Offer for Sale | – Shares / Rs 80 Crore |
| Face Value per share: | Rs. 5 |
| Price Band | Yet to announce |
| Retail Discount | Rs 0 per share |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | Yet to announce |
| Listing will at | BSE, NSE |
| Shares offered in this IPO? |
Shares | Rs. in Crore |
| QIB (50 %) | ||
| NII (15 %) | ||
| RII (35 %) | ||
| Employees | ||
| Total Shares | ||
| Retail portion will be oversubscribed by | Forms. | |
| How to apply in this IPO? | Amount Rs. |
|
| Min Retail Application | ||
| Max Retail Application | ||
| Small HNI (Min) application | ||
| Small HNI (Max) application | ||
| Big HNI Application | ||
| What is the timetable of the IPO? | |
| IPO opens on | Yet to announce |
| IPO Closes on | Yet to announce |
| IPO Allotment on | Yet to announce |
| Unblocking of Asba | Yet to announce |
| Credit of Shares | Yet to announce |
| Listing of Shares | Yet to announce |
| Registered Office of the company RS No. 972, 3rd KM on Gopalapuram Road, West Godavari, Devarapalli – 534 313, Andhra Pradesh, India |
|
| Lead Managers of the IPO Pantomath Capital Advisors |
|
| Registrar to IPO | |
| Bigshare Services Pvt ltd |
| Paramesu Biotech IPO Financial & Analytical Ratios | ||||
| Year | Total Income | Net Profit | EPS | RoNW |
| Rs. in Cr | Rs.in Cr | Rs. | % | |
| 2021-22 | 496.60 | 33.97 | 1.29 | 23.30 |
| 2022-23 | 625.34 | 32.52 | 1.24 | 24.46 |
| 2023-24 | 629.29 | 40.34 | 1.54 | 33.65 |
| Book Value of the Share on 31.3.2024 |
6.29 | |||
| BV of the Share after the IPO |
Rs. | – | ||
| Offer Price at Cap | Rs. | ? | ||
| IPO Ratio Analysis | |
| Price /EPS | ? |
| Price/Book Value | ? |
| Price/BV after IPO | ? |
How Paramesu Biotech IPO compares with the Peers?
Peer Comparison.
| As on date of DRHP | FV | Total | PE |
| Rs. | Income | Ratio of | |
| Rs. In Cr | |||
| Paramesu Bitech | 5 | 629.29 | |
| Sanstar ltd | 2 | 1081.68 | 24.82 |
| Gujarat Ambuja Expo. | 1 | 5071.42 | 16.38 |
| Gulshan Polyols | 1 | 1390.18 | 71.67 |
| Sukhjit Starch | 5 | 1385.03 | 15.67 |
# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Paramesu Biotech IPO Guidance by Paresh Gordhandas, CA & Research Analyst.
We shall post our review once the price, lot and other updates are available to us.
Quicklinks
